Sharon Townson Insider Trades & Stock Holdings

Chief Scientific Officer · Monte Rosa Therapeutics, Inc. · Latest filing Jun 23, 2026

Sharon Townson, Chief Scientific Officer at Monte Rosa Therapeutics, Inc. has 4 Form 4 trades on file since Jun 17, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($57K), net -$57K. Latest filing: disposed of 3K shares of $GLUE on Jun 23, 2026.

Trades on file

4

Open-market bought

$0

Open-market sold

$57K

Net open-market

-$57K

Latest filing

Jun 23, 2026

All insider trades by Sharon Townson

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 23, 2026	$GLUE	Sell (Option exercise)	3K	$0	—			+16.9%	+11.2%		Chief Scientific Officer		—
Jun 23, 2026	$GLUE	Buy (Option exercise)	3K	$6.14	$18.42K			+16.9%	+11.2%		Chief Scientific Officer		—
Jun 17, 2026	$GLUE	Sell (Open-market sale) 10b5-1	3K	$19	$57K			+13.3%	+33.4%		Chief Scientific Officer		—
Jun 17, 2026	$GLUE	Buy (Option exercise)	3K	$6.14	$18.42K			+13.3%	+33.4%		Chief Scientific Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Sharon Townson traded

• $GLUE

Frequently asked questions

Has Sharon Townson been buying or selling stock?

Sharon Townson has 0 open-market purchases and 1 open-market sale on file, net -$57K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Sharon Townson's latest insider trade?

disposed of 3K shares of $GLUE on Jun 23, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.